caffeine has been researched along with Hepatitis, Chronic in 5 studies
Hepatitis, Chronic: INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Subjects with liver cirrhosis and chronic hepatitis, as well as healthy volunteers, were given the oral dose of 300 mg caffeine." | 2.71 | Serum metabolite/caffeine ratios as a test for liver function. ( Flieger, J; Jodynis-Liebert, J; Juszczyk, J; Matuszewska, A, 2004) |
| " A comparison between the single and the "cocktail" dosage did not reveal any significant differences in the pharmacokinetic parameters." | 1.28 | [Simultaneous administration of various model substances for characterizing in vivo biotransformation in chronic liver diseases]. ( Henschel, L; Hoffmann, A; Huster, A; Jorke, D; Kraul, H; Reinhardt, M; Töpfer, R; Truckenbrodt, J, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saab, S | 1 |
| Mallam, D | 1 |
| Cox, GA | 1 |
| Tong, MJ | 1 |
| Jodynis-Liebert, J | 1 |
| Flieger, J | 1 |
| Matuszewska, A | 1 |
| Juszczyk, J | 1 |
| Soto Alvarez, J | 1 |
| Alsar Ortiz, MJ | 1 |
| Truckenbrodt, J | 1 |
| Kraul, H | 1 |
| Huster, A | 1 |
| Töpfer, R | 1 |
| Henschel, L | 1 |
| Hoffmann, A | 1 |
| Reinhardt, M | 1 |
| Jorke, D | 1 |
| Hartleb, M | 1 |
| Nowak, A | 1 |
| Becker, A | 1 |
| Mańczyk, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Development of a Breath Test for Monitoring Liver Metabolic Function in Patients With Chronic Liver Disease and Cirrhosis[NCT00244569] | Phase 3 | 120 participants (Anticipated) | Interventional | 2005-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for caffeine and Hepatitis, Chronic
| Article | Year |
|---|---|
Impact of coffee on liver diseases: a systematic review.
Topics: Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Caffeine; Carcinoma, Hepatocell | 2014 |
1 trial available for caffeine and Hepatitis, Chronic
| Article | Year |
|---|---|
Serum metabolite/caffeine ratios as a test for liver function.
Topics: Adult; Caffeine; Female; Hepatitis, Chronic; Humans; Liver; Liver Cirrhosis; Liver Function Tests; M | 2004 |
3 other studies available for caffeine and Hepatitis, Chronic
| Article | Year |
|---|---|
[The assessment of liver microsomal oxidative capacity via caffeine and antipyrine elimination in patients with chronic active hepatitis: preliminary results].
Topics: Adult; Antipyrine; Caffeine; Female; Hepatitis, Chronic; Humans; Liver Function Tests; Male; Microso | 1992 |
[Simultaneous administration of various model substances for characterizing in vivo biotransformation in chronic liver diseases].
Topics: Biotransformation; Caffeine; Debrisoquin; Dipyrone; Fatty Liver, Alcoholic; Female; Hepatitis, Chron | 1990 |
[Effect of smoking on caffeine elimination by the liver in patients with chronic liver diseases].
Topics: Adolescent; Adult; Aged; Caffeine; Chronic Disease; Fatty Liver, Alcoholic; Hepatitis, Chronic; Huma | 1990 |